• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

States must work quickly to design exchanges

Article

Exchanges will be at the center of the individual and small group markets in the states and their impact is projected to be transformational

Exchanges will be at the center of the individual and small group markets in the states and their impact is projected to be transformational.

Another 35 million people are expected to purchase though the Small Business Health Options Program (SHOP) exchanges, which provide a portal for small employers to make a broad choice of affordable policies available to their employees. In SHOP exchanges, employers with fewer than 100 employees choose a "tier" of plans, and their employees choose the specific policy within that tier that suits their needs and budget.

Under the Patient Protection and Affordable Care Act (PPACA), every state must conduct a decision-making exercise to determine if they will establish an exchange or allow the federal government to do so in lieu of state action. To be clear, PPACA gives states the option to establish the exchange-not whether there will be an exchange operating in the state.

In October, the Department of Health and Human Services (HHS) awarded states grants of roughly $1 million each for the data collection, analysis, legislative and regulatory work needed to design their exchanges. Sometime in 2012, the secretary of HHS will assess the progress of each state.

If she determines that a given state will not have a fully operational exchange by January 2014, the federal government will step in and establish an exchange on the state's behalf. In addition, states will face significant policy choices that will affect how, where and in what form insurance is sold both inside and outside the exchanges.

States have approximately two years to:

This column is written for informational purposes only and should not be construed as legal advice.

Cindy Gillespie is managing director in the public policy practice at McKenna Long & Aldridge, LLP. Previously, she served as counselor to the Massachusetts governor when the state passed its healthcare reform law.

Related Videos
Video 9 - "Denial of Coverage in Fertility Care"
Video 8 - "Risks of Miscarriage and Multiple Births Associated with Fertility Care"
Video 7 - "Fertility Preservation: Egg Freezing Versus Embryo Freezing"
Video 6 - "Family Building Costs, Barriers, and Dropout Rates Associated with Fertility Care"
Video 5 - "Closing Payer Gaps and Improving Fertility Care Access"
Video 4 - "Increasing Employer Coverage and Maximizing Fertility Benefits "
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Video 3 - "Improving IVF Success Rates & Utilizing AI in Fertility Health Care"
Video 2 - "Holistic Fertility Management and Payer Collaboration"
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Related Content
© 2024 MJH Life Sciences

All rights reserved.